by 
Bone densitometers are medical devices that are used to measure bone loss due to osteoporosis and other bone-related diseases. Bone densitometers employ dual-energy X-ray absorptiometry (DEXA) technology to compare bone mineral density to that of a healthy young adult. They are commonly used during initial osteoporosis screening and for monitoring response to treatment. With the growing geriatric population and increasing prevalence of osteoporosis worldwide, the demand for bone densitometers is on the rise.
The global bone densitometers market is estimated to be valued at US$ 313.05 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing prevalence of osteoporosis, as referred in the heading, remains a key factor driving the growth of the bone densitometers market. As per the International Osteoporosis Foundation, osteoporosis causes more than 8.9 million fractures annually worldwide, with an osteoporotic fracture occurring approximately every 3 seconds. Around 200 million people are estimated to suffer from the disease globally. This creates significant demand for bone densitometry procedures for screening and monitoring treatment response. Additionally, technological advancements in densitometers, leading to the introduction of portable, high-precision devices, are boosting market expansion. However, stringent regulatory requirements and the high cost of bone densitometry procedures may limit market growth to a certain extent over the forecast period.
Segment Analysis
The global bone densitometers market is dominated by dual energy X-ray absorptiometry (DEXA) segment. DEXA segment held around 75% market share in 2022 owing to its advantages such as high precision, low radiation dose, and fast scan time. Quantitative computed tomography (QCT) segment is expected to witness fastest growth during the forecast period due to its ability to assess bone mineral density and bone structure.
PEST Analysis
Political: Increased health awareness initiatives by governments worldwide regarding osteoporosis is positively impacting the market.
Economic: Rising geriatric population and improving reimbursement policies is fueling the market growth.
Social: Growing cases of osteoporosis owing to changing lifestyle and increasing obesity rates is driving the demand.
Technological: Advancements in CT and ultrasound technologies is enabling development of novel bone densitometers with improved capabilities and reduced radiation exposure.
Key Takeaways
The global bone densitometers market size was valued at US$ 313.05 Mn in 2024 and is expected to reach US$ 442.17 Mn by 2030, expanding at a CAGR of 4.7% during the forecast period.
Regional analysis: North America dominated the global market in 2024 owing to presence of major players and rising geriatric population in the US and Canada suffering from osteoporosis. Asia Pacific is anticipated to witness fastest growth during the forecast period supported by improving healthcare infrastructure and increasing medical tourism in the region.
Key players: Key players operating in the bone densitometers market are GE Healthcare, Hologic, Inc., Swissray Global Healthcare Holding, and BeamMed Ltd. GE Healthcare currently dominates the global market driven by its broad product portfolio including dual energy X-ray bone densitometers and CT scanners. Hologic, Inc. offers novel ultrasound and DXA systems widening its customer base worldwide.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
